BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30615629)

  • 1. Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis.
    Bansal M; He J; Peyton M; Kustagi M; Iyer A; Comb M; White M; Minna JD; Califano A
    PLoS One; 2019; 14(1):e0208646. PubMed ID: 30615629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.
    Ali NA; Wu J; Hochgräfe F; Chan H; Nair R; Ye S; Zhang L; Lyons RJ; Pinese M; Lee HC; Armstrong N; Ormandy CJ; Clark SJ; Swarbrick A; Daly RJ
    Breast Cancer Res; 2014 Sep; 16(5):437. PubMed ID: 25200860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.
    Schweppe DK; Rigas JR; Gerber SA
    J Proteomics; 2013 Oct; 91():286-96. PubMed ID: 23911959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.
    Zhang X; Nguyen KD; Rudnick PA; Roper N; Kawaler E; Maity TK; Awasthi S; Gao S; Biswas R; Venugopalan A; Cultraro CM; Fenyö D; Guha U
    Mol Cell Proteomics; 2019 Apr; 18(4):622-641. PubMed ID: 30617155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
    Sudhir PR; Hsu CL; Wang MJ; Wang YT; Chen YJ; Sung TY; Hsu WL; Yang UC; Chen JY
    PLoS One; 2011; 6(5):e20199. PubMed ID: 21637843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Proteomic Characterization of Human Lung Adenocarcinoma.
    Xu JY; Zhang C; Wang X; Zhai L; Ma Y; Mao Y; Qian K; Sun C; Liu Z; Jiang S; Wang M; Feng L; Zhao L; Liu P; Wang B; Zhao X; Xie H; Yang X; Zhao L; Chang Y; Jia J; Wang X; Zhang Y; Wang Y; Yang Y; Wu Z; Yang L; Liu B; Zhao T; Ren S; Sun A; Zhao Y; Ying W; Wang F; Wang G; Zhang Y; Cheng S; Qin J; Qian X; Wang Y; Li J; He F; Xiao T; Tan M
    Cell; 2020 Jul; 182(1):245-261.e17. PubMed ID: 32649877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
    J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
    Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
    Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.
    Hammond DE; Hyde R; Kratchmarova I; Beynon RJ; Blagoev B; Clague MJ
    J Proteome Res; 2010 May; 9(5):2734-42. PubMed ID: 20222723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSLP signaling network revealed by SILAC-based phosphoproteomics.
    Zhong J; Kim MS; Chaerkady R; Wu X; Huang TC; Getnet D; Mitchell CJ; Palapetta SM; Sharma J; O'Meally RN; Cole RN; Yoda A; Moritz A; Loriaux MM; Rush J; Weinstock DM; Tyner JW; Pandey A
    Mol Cell Proteomics; 2012 Jun; 11(6):M112.017764. PubMed ID: 22345495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks.
    Su SP; Flashner-Abramson E; Klein S; Gal M; Lee RS; Wu J; Levitzki A; Daly RJ
    Mol Cancer Ther; 2018 May; 17(5):931-942. PubMed ID: 29440449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DIONESUS algorithm provides scalable and accurate reconstruction of dynamic phosphoproteomic networks to reveal new drug targets.
    Ciaccio MF; Chen VC; Jones RB; Bagheri N
    Integr Biol (Camb); 2015 Jul; 7(7):776-91. PubMed ID: 26057728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors.
    Stopfer LE; Flower CT; Gajadhar AS; Patel B; Gallien S; Lopez-Ferrer D; White FM
    Cancer Res; 2021 May; 81(9):2495-2509. PubMed ID: 33509940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
    Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
    Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase,
    Goel RK; Paczkowska M; Reimand J; Napper S; Lukong KE
    Mol Cell Proteomics; 2018 May; 17(5):925-947. PubMed ID: 29496907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling.
    Mäusbacher N; Schreiber TB; Machatti M; Schaab C; Daub H
    Proteomics; 2012 Dec; 12(23-24):3485-98. PubMed ID: 23090842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.
    Stokes MP; Farnsworth CL; Moritz A; Silva JC; Jia X; Lee KA; Guo A; Polakiewicz RD; Comb MJ
    Mol Cell Proteomics; 2012 May; 11(5):187-201. PubMed ID: 22322096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.